US & European Markets for Cartilage Repair - 16 Countries (2010-2021)
|出版商||iData Research Inc.||商品編碼||338827|
|出版日期||內容資訊||英文 80 Pages
|美國·歐洲的軟骨修復市場:16個國家 (2010年∼2021年) US & European Markets for Cartilage Repair - 16 Countries (2010-2021)|
|出版日期: 2015年06月01日||內容資訊: 英文 80 Pages||
Articular cartilage is a connective tissue that lines the ends of bones in joints. It provides shock absorption within the joint and prevents abrasion from occurring to the articular surfaces of bone. Cartilage, in its various forms, is found in intervertebral discs, as the articular lining for joint surfaces and in the meniscal pads of the knees. All types of this tissue are poorly vascularized and, as proper healing requires adequate blood flow, cartilage is one of the slowest healing tissues of the body. Osteoarthritis is cumulative trauma that eventually wears away at cartilaginous surfaces, exposing the underlying bone to additional wear. There are few alternatives to osteobiologic cartilage repair. Damage to cartilage is difficult to treat because the tissue lacks blood supply and has limited capacity for self repair.
(US) The use of cartilage repair products or allografts only accounted for just over 5% of all cartilage repair procedures in 2014. The efficacy of a cartilage repair technique is always compared to the success of a microfracture procedure, which provides reasonable relief and is inexpensive to perform. A cartilage repair implant, which is likely to feature a high price to cover development costs, must justify the premium pricing with sufficiently superior results. This price premium is why most cartilage repair segments are growing at a slow rate.
In 2013, the total European cartilage repair market, including osteochondral cartilage allografts, osteochondral cartilage autografts, meniscal allografts and autologous chondrocyte implantation (ACI) was valued at €77 million. This was a X% increase over 2012. The economic downturn affected the growth of the market. Because this is a fairly new market, especially with regards to ACI treatment, the market has grown significantly over the last few years. It is expected to continue growing at an accelerating pace.